Michelle Minor
Psychiatric/Mental Health · Baton Rouge, LANPI 1558483560
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,943, more than ten times the $16 reported in 2021.
Across 139 payments — averaging $36.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$612
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$543
- Alkermes, Inc.$448
- Otsuka America Pharmaceutical, Inc.$386
- Neurocrine Biosciences, Inc.$355
- Johnson & Johnson$315
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,94398%
- Education$1112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $612 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $543 |
| Alkermes, Inc. | 11 | $448 |
| Otsuka America Pharmaceutical, Inc. | 11 | $386 |
| Neurocrine Biosciences, Inc. | 10 | $355 |
| Johnson & Johnson | 10 | $315 |
| Vanda Pharmaceuticals Inc. | 10 | $305 |
| E.r. Squibb & Sons, L.L.C. | 10 | $263 |
| AbbVie | 11 | $255 |
| Abbott | 2 | $238 |
| Neurelis, Inc. | 2 | $192 |
| AstraZeneca(2 entities) | 2 | $170 |
| Lundbeck LLC | 6 | $136 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Kyowa Kirin, Inc. | 1 | $118 |
| Novo Nordisk | 1 | $111 |
| Gilead | 1 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $94 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Indivior Inc. | 2 | $39 |
| Braeburn Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$902
- CAPLYTA$244
- ABILIFY ASIMTUFII$239
- ABILIFY MAINTENA$239
- VOQUEZNA$124
- Fanapt$124
- FreeStyle Libre 2$123
- DUPIXENT$122
- INVEGA SUSTENNA$120
- FREESTYLE LIBRE 3$115
- VRAYLAR$101
- VALTOCO$100
- COBENFY$100
How this compares
$5,055 in reported general payments places this provider in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Baton Rouge
- Amy LacoutureBaton Rouge$663K
- Yolanda CockerhamBaton Rouge$11K
- Drew DykesBaton Rouge$11K
- Tiffany JordanBaton Rouge$10K
- Elizabeth CasselberryBaton Rouge$9K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.